In in vitro and in vivo studies of breast cancer, the repression of E-cadherin expression occurs involving the direct binding of Twist1 to the E-cadherin promoter, such that the downregulation of E-cadherin attenuates cell–cell adhesion and enhances migration and invasion [26]. Here, CDH1 is linked to breast carcinoma.